Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
<p>Tuberculosis (TB), caused by infection with <em>Mycobacterium tuberculosis (M.tb)</em>, remains a global health problem and although BCG offers some protection against childhood disseminated disease and other mycobacterial infections, its efficacy against pulmonary TB varies bet...
Príomhchruthaitheoir: | Griffiths, K |
---|---|
Rannpháirtithe: | McShane, H |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
2012
|
Ábhair: |
Míreanna comhchosúla
Míreanna comhchosúla
-
Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
de réir: Ronan, E
Foilsithe / Cruthaithe: (2011) -
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
de réir: Hennig, B, et al.
Foilsithe / Cruthaithe: (2008) -
Innate immune responses to tuberculosis vaccines
de réir: Matsumiya, M
Foilsithe / Cruthaithe: (2014) -
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
de réir: Harris, S, et al.
Foilsithe / Cruthaithe: (2013) -
Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
de réir: Antrobus, R
Foilsithe / Cruthaithe: (2014)